EUCAST News
Here you can find the latest news and updates from EUCAST.
News from VetCAST - publication on PK/PD for benzylpenicillin in horses
Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses. E.Lallemande et al, October,...[more]
bioMerieux has still not withdrawn the malfunctioning colistin AST material
This is a general and iterated EUCAST warning against material sold by bioMerieux for susceptibility testing (AST) of colistin. It is years since it was conclusively shown by scientists that material for AST sold by bioMerieux...[more]
RAST breakpoints for prolonged incubation (16-20h) now published in JAC
Recently we made breakpoints available (on the website) for RAST incubation beyond the standard 4, 6 and 8h for when reading at those incubation times is not prectical. Now the rationale for this is published in the Journal of...[more]
Methods document on MIC testing of yeasts updated by AFST
The Edef 7.4 document "Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts" has been updated (v. 7.4, 13 October, 2023). [more]
Consultation on proposed changes in the 2024 (v 14.0) breakpoint table
In preparation for next year´s table (EUCAST Breakpoint Table 14.0, 2024), EUCAST aims to institute several changes as listed below. Each change is minor but may still have unforeseen consequences in individual laboratories. If...[more]
SOPs 12 and 13 on the development of appropriate disks content published
EUCAST and CLSI have developed joint critera for determining the appropriate disk content (potency) for antibiotic disks used for disk diffusion in methods recommended by EUCAST and CLSI. SOPs 12 and 13 describe procedures for...[more]
Optimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring
Optimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring; Boston, United States, 9 – 10 October 2023. [more]
